Senate Panel OKs NIH Budget Boost

The $2 billion increase in federal funding for the National Institutes of Health would be the biggest in more than a decade.

Written byAmanda B. Keener
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA

The US National Institutes of Health (NIH) is on its way to receiving its largest funding increase since 2003 thanks to the approval of two draft bills by panels in the House of Representatives and the Senate this week. Although the House panel approved a budget that falls $900 million short of the Senate panel’s $2 billion raise, both bills exceed President Obama’s request to bring the $30.1 billion budget up by 3.3 percent.

“The Senate mark is obviously the best subcommittee action we have seen for NIH in more than 12 years,” Pat White, president of the biomedical research funding lobbyist group ACT for NIH, told Science Insider. “It shows that there is real momentum on a bipartisan basis in the House and the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies